Shiruyeh Schokrpur

5PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 17, 2026
Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC.

|Jul 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy.

Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang

|Jul 14, 2025
Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma.

Cheyanne K Shinn, Robert Saddawi-Konefka, Catherina L Salanga

|Jan 24, 2025
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.

Sandip P Patel, Eleanor Cano-Linson, Young Kwang Chae

|Jan 22, 2025
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.

Amir Ferry, Kianoosh M Mempel, Alexander Monell

Pageof 1

Frequent Collaborators

4 joint publications

Robert Saddawi-Konefka

3 joint publications

J Silvio Gutkind

2 joint publications

Tracy M Handel

2 joint publications

Cheyanne K Shinn